Fig. 2: Radiographic responses to CNS metastases of metastatic breast cancer with SG. | npj Breast Cancer

Fig. 2: Radiographic responses to CNS metastases of metastatic breast cancer with SG.

From: Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases

Fig. 2

Baseline and Central Nervous system (CNS) response assessment by MRI Brain imaging of patients with metastatic breast cancer patients with CNS metastases treated with sacituzumab govitecan. LMD: leptomeningeal disease;BM: Brain Metastases. Patient #11 with stable BM received RT (SRS) less than two months before the initiation of OS. Patient #27 was irradiated for 9 months on another lesion (temporal) and patient #31 did not receive any irradiation before the SG.

Back to article page